CN Stock MarketDetailed Quotes

300878 Zhejiang Wecome Pharmaceutical

Watchlist
  • 20.57
  • +1.25+6.47%
Market Closed Dec 12 15:00 CST
2.98BMarket Cap-89.43P/E (TTM)

Zhejiang Wecome Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
65.61%324.27M
-27.16%320.58M
6.22%226.18M
102.88%330.16M
1.61%195.81M
115.37%440.15M
9.95%212.93M
-42.04%162.74M
-39.52%192.7M
-44.67%204.37M
Transactional financial assets
----
----
----
--245.56M
--241M
----
----
----
----
----
Notes receivable and accounts receivable
-23.26%250.02M
-19.70%262.38M
-9.50%279.78M
-21.90%212.13M
-20.71%325.82M
-22.37%326.74M
-27.32%309.15M
-27.31%271.62M
0.29%410.94M
14.95%420.87M
-Accounts receivable
-23.26%250.02M
-19.70%262.38M
-9.50%279.78M
-21.90%212.13M
-20.71%325.82M
-22.37%326.74M
-27.32%309.15M
-27.31%271.62M
0.29%410.94M
14.95%420.87M
Other receivables (including interest and dividends)
750.18%54.12M
134.37%7.53M
-94.67%12.42M
-96.85%11.55M
-44.58%6.37M
-71.94%3.21M
8,903.18%232.79M
13,194.84%366.31M
-67.20%11.49M
-64.79%11.45M
-Other receivable
----
134.37%7.53M
----
----
----
-71.94%3.21M
----
----
----
-64.79%11.45M
Advance payment
-84.05%4.12M
-64.14%7.52M
-66.80%8.01M
-84.76%4.8M
-34.63%25.84M
-48.35%20.98M
-40.71%24.11M
-15.91%31.49M
-24.55%39.52M
-18.19%40.61M
Inventories
-31.35%109.06M
-1.37%135.22M
1.29%123.35M
31.69%153.78M
-21.04%158.87M
22.49%137.1M
-2.69%121.77M
-9.82%116.78M
101.64%201.2M
17.55%111.92M
Receivable financing
48.68%22.74M
253.50%32.03M
-6.53%45.09M
-15.14%52.84M
-12.35%15.3M
-66.84%9.06M
30.67%48.25M
71.83%62.26M
-13.92%17.45M
137.13%27.32M
Other current assets
77.90%24.12M
94.64%18.61M
-41.31%12.53M
5.04%23.93M
-32.12%13.56M
94.76%9.56M
84.25%21.35M
135.07%22.78M
1,896.89%19.97M
50.59%4.91M
Total current assets
-19.75%788.46M
-17.21%783.87M
-27.10%707.36M
0.07%1.03B
9.99%982.56M
15.26%946.8M
16.08%970.36M
18.84%1.03B
-4.65%893.27M
-11.45%821.46M
Non Current assets
Other non-current financial assets
0.00%25M
0.00%25M
0.00%25M
0.00%25M
--25M
--25M
61.99%25M
25.23%25M
----
----
Investment real estate
53.50%8.2M
53.74%8.33M
57.87%8.68M
-2.50%5.43M
-4.67%5.34M
-3.92%5.42M
-3.17%5.5M
-2.44%5.57M
-2.43%5.61M
-2.41%5.64M
Long-term equity investment
----
----
--1.56M
--1.55M
----
----
----
----
----
----
Fixed assets
----
1.54%538.69M
----
----
----
-3.97%530.52M
----
----
----
345.17%552.46M
Constru in process
----
-15.06%346.49M
----
----
----
105.48%407.93M
----
----
----
-57.54%198.53M
Intangible assets
-6.18%33.93M
-4.21%35.1M
-5.14%35.2M
-5.04%35.67M
-4.93%36.16M
-4.70%36.64M
-4.58%37.1M
-4.44%37.56M
-4.48%38.04M
9.29%38.45M
Goodwill
-36.59%17.18M
-0.43%27.04M
-0.51%27.05M
-0.51%27.08M
55.45%27.1M
55.21%27.15M
54.85%27.19M
54.50%27.22M
6.26%17.43M
--17.49M
Long deferred expense
-57.38%2.39M
-35.25%4M
-18.91%4.52M
-16.90%5.07M
-15.61%5.6M
-15.00%6.18M
-28.50%5.57M
-13.10%6.11M
-14.35%6.63M
-12.31%7.27M
Deferred tax assets
149.81%31.21M
103.69%28.85M
39.52%26M
62.81%27.07M
5.27%12.5M
-38.02%14.17M
-18.85%18.64M
-32.40%16.63M
100.55%11.87M
221.24%22.86M
Usufruct assets
-64.98%8.03M
0.25%25.94M
-8.74%26.26M
-14.51%27.52M
-16.22%22.95M
-14.58%25.88M
-21.83%28.78M
-14.40%32.19M
163.37%27.39M
175.68%30.29M
Other non current assets
1,315.33%11.51M
1,759.18%15.12M
2,886.76%28.36M
2,610.94%25.74M
--813K
--813K
--949.5K
-67.32%949.5K
----
----
Total non current assets
-5.04%1.05B
-2.33%1.05B
-1.66%1.03B
14.92%1.01B
20.92%1.1B
23.68%1.08B
21.45%1.05B
6.96%880.54M
21.98%911.45M
26.69%872.99M
Total assets
-11.97%1.84B
-9.28%1.84B
-13.89%1.74B
6.90%2.05B
15.51%2.08B
19.60%2.03B
18.81%2.02B
13.06%1.91B
7.17%1.8B
4.81%1.69B
Liabilities
Current liabilities
Short term loan
-79.25%60.01M
-76.82%60.16M
-99.95%150K
1.81%261.9M
261.10%289.16M
159.36%259.5M
502.69%307.37M
413.88%257.25M
60.16%80.08M
--100.05M
Notes payable and accounts payable
-48.66%47.03M
-30.03%65.17M
-29.78%70.49M
5.60%101.12M
-50.38%91.6M
15.62%93.15M
-1.91%100.38M
-1.55%95.75M
148.71%184.6M
-16.38%80.57M
-Notes payable
-67.06%6.96M
-26.68%10.36M
-18.33%11.54M
61.60%17.81M
-86.50%21.14M
39.87%14.13M
38.51%14.13M
70.41%11.02M
1,938.17%156.62M
-11.45%10.11M
-Accounts payable
-43.14%40.06M
-30.63%54.81M
-31.65%58.95M
-1.68%83.31M
151.86%70.46M
12.14%79.01M
-6.38%86.25M
-6.67%84.73M
-57.95%27.98M
-17.04%70.46M
Contract liabilities
-14.63%13.16M
72.03%14.53M
-10.35%9.16M
-8.30%14.38M
101.35%15.41M
65.34%8.44M
21.67%10.22M
89.86%15.68M
35.56%7.65M
15.12%5.11M
Advance receipts
--806.3K
--122.62K
1,186.24%564.59K
189.31%317.48K
----
----
-51.82%43.89K
-14.36%109.74K
----
----
Salaries payable
-24.61%6.23M
10.60%8.37M
24.83%8.12M
22.64%12.41M
1.16%8.27M
-8.71%7.57M
-11.01%6.5M
-4.27%10.12M
-8.36%8.17M
-4.81%8.29M
Taxs payable
199.08%6.1M
4.78%3.42M
9.97%7.07M
25.96%5.44M
11.06%2.04M
-59.58%3.26M
14.59%6.43M
-62.13%4.32M
-92.20%1.84M
-63.43%8.06M
Other payable (including interest and dividends)
115.66%15.02M
62.05%12.46M
137.02%22M
46.98%23.59M
-53.53%6.96M
-59.15%7.69M
-74.71%9.28M
-61.19%16.05M
-80.58%14.99M
-74.03%18.82M
-Other payable
----
62.05%12.46M
----
----
----
-59.15%7.69M
----
----
----
-74.03%18.82M
Non current liabilities due within one year
-77.07%2.61M
-16.80%9.79M
-9.79%10.25M
-13.16%10.21M
25.86%11.37M
18.18%11.76M
-1.61%11.37M
-4.34%11.76M
--9.04M
--9.95M
Other current liabilities
-14.64%1.71M
72.34%1.89M
-10.40%1.19M
-8.42%1.86M
101.90%2M
65.74%1.1M
21.67%1.33M
90.00%2.03M
35.20%992.18K
14.70%660.93K
Total current liabilities
-64.23%152.67M
-55.18%175.9M
-71.52%129M
4.40%431.23M
38.87%426.83M
69.52%392.46M
102.12%452.93M
77.74%413.07M
27.95%307.36M
13.17%231.51M
Current liabilities
Long term loan
118.32%272M
158.76%272M
139.86%171.82M
349.03%149.95M
--124.59M
--105.12M
--71.63M
--33.39M
----
----
Deferred tax liabilities
-85.81%883.22K
-66.38%2.11M
-70.20%1.88M
-73.49%2.03M
-13.37%6.22M
-13.34%6.28M
-7.46%6.31M
11.38%7.67M
32.57%7.18M
40.26%7.25M
Long term deferred income
10.88%39.98M
10.81%40.97M
20.20%41.93M
31.18%42.83M
50.27%36.06M
51.41%36.97M
41.01%34.88M
30.59%32.65M
-5.05%24M
-4.41%24.42M
Lease liabilities
-10.73%5.48M
28.24%11.81M
-21.68%10.72M
-21.07%13.18M
-58.28%6.13M
-45.55%9.21M
-30.89%13.69M
-16.44%16.71M
40.25%14.7M
54.13%16.91M
Total non current liabilities
84.00%318.34M
107.45%326.88M
78.90%226.35M
130.03%208M
277.06%173.01M
224.41%157.57M
146.29%126.52M
74.28%90.42M
11.43%45.88M
16.54%48.57M
Total liabilities
-21.48%471.01M
-8.59%502.79M
-38.67%355.35M
26.96%639.23M
69.81%599.83M
96.38%550.03M
110.36%579.45M
77.11%503.49M
25.53%353.24M
13.74%280.08M
Shareholders equity
Paid-in capital
0.00%144.79M
0.00%144.79M
0.00%144.79M
0.00%144.79M
0.00%144.79M
0.00%144.79M
80.00%144.79M
80.00%144.79M
80.00%144.79M
80.00%144.79M
Capital reserve funds
0.00%680.77M
0.00%680.77M
0.00%680.77M
0.00%680.77M
0.00%680.77M
0.00%680.77M
-8.64%680.77M
-8.64%680.77M
-8.64%680.77M
-8.64%680.77M
Surplus reserve funds
6.60%65.01M
6.60%65.01M
6.60%65.01M
5.95%65.01M
3.28%60.99M
3.28%60.99M
3.28%60.99M
3.91%61.36M
0.00%59.06M
0.00%59.06M
Retained profit
-12.61%507.82M
-17.08%477.92M
-2.95%523.41M
-2.29%499.24M
3.18%581.12M
9.53%576.39M
0.69%539.3M
-0.35%510.93M
10.63%563.19M
9.64%526.25M
Less:Treasury stock
--50M
--50M
--50M
----
----
----
----
----
----
----
Shareholders equity without minority interests
-8.13%1.35B
-9.87%1.32B
-4.34%1.36B
-0.58%1.39B
1.37%1.47B
3.69%1.46B
0.40%1.43B
0.04%1.4B
3.88%1.45B
3.39%1.41B
Minority interests
-8.77%15.64M
26.82%17.15M
42.34%18.66M
33.37%17.6M
365.58%17.14M
285.87%13.52M
312.58%13.11M
12.66%13.2M
-58.84%3.68M
-40.75%3.5M
Total shareholder equity
-8.13%1.36B
-9.54%1.34B
-3.91%1.38B
-0.26%1.41B
2.30%1.48B
4.39%1.48B
1.09%1.44B
0.14%1.41B
3.48%1.45B
3.20%1.41B
Total liabilityies and equity
-11.97%1.84B
-9.28%1.84B
-13.89%1.74B
6.90%2.05B
15.51%2.08B
19.60%2.03B
18.81%2.02B
13.06%1.91B
7.17%1.8B
4.81%1.69B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 65.61%324.27M-27.16%320.58M6.22%226.18M102.88%330.16M1.61%195.81M115.37%440.15M9.95%212.93M-42.04%162.74M-39.52%192.7M-44.67%204.37M
Transactional financial assets --------------245.56M--241M--------------------
Notes receivable and accounts receivable -23.26%250.02M-19.70%262.38M-9.50%279.78M-21.90%212.13M-20.71%325.82M-22.37%326.74M-27.32%309.15M-27.31%271.62M0.29%410.94M14.95%420.87M
-Accounts receivable -23.26%250.02M-19.70%262.38M-9.50%279.78M-21.90%212.13M-20.71%325.82M-22.37%326.74M-27.32%309.15M-27.31%271.62M0.29%410.94M14.95%420.87M
Other receivables (including interest and dividends) 750.18%54.12M134.37%7.53M-94.67%12.42M-96.85%11.55M-44.58%6.37M-71.94%3.21M8,903.18%232.79M13,194.84%366.31M-67.20%11.49M-64.79%11.45M
-Other receivable ----134.37%7.53M-------------71.94%3.21M-------------64.79%11.45M
Advance payment -84.05%4.12M-64.14%7.52M-66.80%8.01M-84.76%4.8M-34.63%25.84M-48.35%20.98M-40.71%24.11M-15.91%31.49M-24.55%39.52M-18.19%40.61M
Inventories -31.35%109.06M-1.37%135.22M1.29%123.35M31.69%153.78M-21.04%158.87M22.49%137.1M-2.69%121.77M-9.82%116.78M101.64%201.2M17.55%111.92M
Receivable financing 48.68%22.74M253.50%32.03M-6.53%45.09M-15.14%52.84M-12.35%15.3M-66.84%9.06M30.67%48.25M71.83%62.26M-13.92%17.45M137.13%27.32M
Other current assets 77.90%24.12M94.64%18.61M-41.31%12.53M5.04%23.93M-32.12%13.56M94.76%9.56M84.25%21.35M135.07%22.78M1,896.89%19.97M50.59%4.91M
Total current assets -19.75%788.46M-17.21%783.87M-27.10%707.36M0.07%1.03B9.99%982.56M15.26%946.8M16.08%970.36M18.84%1.03B-4.65%893.27M-11.45%821.46M
Non Current assets
Other non-current financial assets 0.00%25M0.00%25M0.00%25M0.00%25M--25M--25M61.99%25M25.23%25M--------
Investment real estate 53.50%8.2M53.74%8.33M57.87%8.68M-2.50%5.43M-4.67%5.34M-3.92%5.42M-3.17%5.5M-2.44%5.57M-2.43%5.61M-2.41%5.64M
Long-term equity investment ----------1.56M--1.55M------------------------
Fixed assets ----1.54%538.69M-------------3.97%530.52M------------345.17%552.46M
Constru in process -----15.06%346.49M------------105.48%407.93M-------------57.54%198.53M
Intangible assets -6.18%33.93M-4.21%35.1M-5.14%35.2M-5.04%35.67M-4.93%36.16M-4.70%36.64M-4.58%37.1M-4.44%37.56M-4.48%38.04M9.29%38.45M
Goodwill -36.59%17.18M-0.43%27.04M-0.51%27.05M-0.51%27.08M55.45%27.1M55.21%27.15M54.85%27.19M54.50%27.22M6.26%17.43M--17.49M
Long deferred expense -57.38%2.39M-35.25%4M-18.91%4.52M-16.90%5.07M-15.61%5.6M-15.00%6.18M-28.50%5.57M-13.10%6.11M-14.35%6.63M-12.31%7.27M
Deferred tax assets 149.81%31.21M103.69%28.85M39.52%26M62.81%27.07M5.27%12.5M-38.02%14.17M-18.85%18.64M-32.40%16.63M100.55%11.87M221.24%22.86M
Usufruct assets -64.98%8.03M0.25%25.94M-8.74%26.26M-14.51%27.52M-16.22%22.95M-14.58%25.88M-21.83%28.78M-14.40%32.19M163.37%27.39M175.68%30.29M
Other non current assets 1,315.33%11.51M1,759.18%15.12M2,886.76%28.36M2,610.94%25.74M--813K--813K--949.5K-67.32%949.5K--------
Total non current assets -5.04%1.05B-2.33%1.05B-1.66%1.03B14.92%1.01B20.92%1.1B23.68%1.08B21.45%1.05B6.96%880.54M21.98%911.45M26.69%872.99M
Total assets -11.97%1.84B-9.28%1.84B-13.89%1.74B6.90%2.05B15.51%2.08B19.60%2.03B18.81%2.02B13.06%1.91B7.17%1.8B4.81%1.69B
Liabilities
Current liabilities
Short term loan -79.25%60.01M-76.82%60.16M-99.95%150K1.81%261.9M261.10%289.16M159.36%259.5M502.69%307.37M413.88%257.25M60.16%80.08M--100.05M
Notes payable and accounts payable -48.66%47.03M-30.03%65.17M-29.78%70.49M5.60%101.12M-50.38%91.6M15.62%93.15M-1.91%100.38M-1.55%95.75M148.71%184.6M-16.38%80.57M
-Notes payable -67.06%6.96M-26.68%10.36M-18.33%11.54M61.60%17.81M-86.50%21.14M39.87%14.13M38.51%14.13M70.41%11.02M1,938.17%156.62M-11.45%10.11M
-Accounts payable -43.14%40.06M-30.63%54.81M-31.65%58.95M-1.68%83.31M151.86%70.46M12.14%79.01M-6.38%86.25M-6.67%84.73M-57.95%27.98M-17.04%70.46M
Contract liabilities -14.63%13.16M72.03%14.53M-10.35%9.16M-8.30%14.38M101.35%15.41M65.34%8.44M21.67%10.22M89.86%15.68M35.56%7.65M15.12%5.11M
Advance receipts --806.3K--122.62K1,186.24%564.59K189.31%317.48K---------51.82%43.89K-14.36%109.74K--------
Salaries payable -24.61%6.23M10.60%8.37M24.83%8.12M22.64%12.41M1.16%8.27M-8.71%7.57M-11.01%6.5M-4.27%10.12M-8.36%8.17M-4.81%8.29M
Taxs payable 199.08%6.1M4.78%3.42M9.97%7.07M25.96%5.44M11.06%2.04M-59.58%3.26M14.59%6.43M-62.13%4.32M-92.20%1.84M-63.43%8.06M
Other payable (including interest and dividends) 115.66%15.02M62.05%12.46M137.02%22M46.98%23.59M-53.53%6.96M-59.15%7.69M-74.71%9.28M-61.19%16.05M-80.58%14.99M-74.03%18.82M
-Other payable ----62.05%12.46M-------------59.15%7.69M-------------74.03%18.82M
Non current liabilities due within one year -77.07%2.61M-16.80%9.79M-9.79%10.25M-13.16%10.21M25.86%11.37M18.18%11.76M-1.61%11.37M-4.34%11.76M--9.04M--9.95M
Other current liabilities -14.64%1.71M72.34%1.89M-10.40%1.19M-8.42%1.86M101.90%2M65.74%1.1M21.67%1.33M90.00%2.03M35.20%992.18K14.70%660.93K
Total current liabilities -64.23%152.67M-55.18%175.9M-71.52%129M4.40%431.23M38.87%426.83M69.52%392.46M102.12%452.93M77.74%413.07M27.95%307.36M13.17%231.51M
Current liabilities
Long term loan 118.32%272M158.76%272M139.86%171.82M349.03%149.95M--124.59M--105.12M--71.63M--33.39M--------
Deferred tax liabilities -85.81%883.22K-66.38%2.11M-70.20%1.88M-73.49%2.03M-13.37%6.22M-13.34%6.28M-7.46%6.31M11.38%7.67M32.57%7.18M40.26%7.25M
Long term deferred income 10.88%39.98M10.81%40.97M20.20%41.93M31.18%42.83M50.27%36.06M51.41%36.97M41.01%34.88M30.59%32.65M-5.05%24M-4.41%24.42M
Lease liabilities -10.73%5.48M28.24%11.81M-21.68%10.72M-21.07%13.18M-58.28%6.13M-45.55%9.21M-30.89%13.69M-16.44%16.71M40.25%14.7M54.13%16.91M
Total non current liabilities 84.00%318.34M107.45%326.88M78.90%226.35M130.03%208M277.06%173.01M224.41%157.57M146.29%126.52M74.28%90.42M11.43%45.88M16.54%48.57M
Total liabilities -21.48%471.01M-8.59%502.79M-38.67%355.35M26.96%639.23M69.81%599.83M96.38%550.03M110.36%579.45M77.11%503.49M25.53%353.24M13.74%280.08M
Shareholders equity
Paid-in capital 0.00%144.79M0.00%144.79M0.00%144.79M0.00%144.79M0.00%144.79M0.00%144.79M80.00%144.79M80.00%144.79M80.00%144.79M80.00%144.79M
Capital reserve funds 0.00%680.77M0.00%680.77M0.00%680.77M0.00%680.77M0.00%680.77M0.00%680.77M-8.64%680.77M-8.64%680.77M-8.64%680.77M-8.64%680.77M
Surplus reserve funds 6.60%65.01M6.60%65.01M6.60%65.01M5.95%65.01M3.28%60.99M3.28%60.99M3.28%60.99M3.91%61.36M0.00%59.06M0.00%59.06M
Retained profit -12.61%507.82M-17.08%477.92M-2.95%523.41M-2.29%499.24M3.18%581.12M9.53%576.39M0.69%539.3M-0.35%510.93M10.63%563.19M9.64%526.25M
Less:Treasury stock --50M--50M--50M----------------------------
Shareholders equity without minority interests -8.13%1.35B-9.87%1.32B-4.34%1.36B-0.58%1.39B1.37%1.47B3.69%1.46B0.40%1.43B0.04%1.4B3.88%1.45B3.39%1.41B
Minority interests -8.77%15.64M26.82%17.15M42.34%18.66M33.37%17.6M365.58%17.14M285.87%13.52M312.58%13.11M12.66%13.2M-58.84%3.68M-40.75%3.5M
Total shareholder equity -8.13%1.36B-9.54%1.34B-3.91%1.38B-0.26%1.41B2.30%1.48B4.39%1.48B1.09%1.44B0.14%1.41B3.48%1.45B3.20%1.41B
Total liabilityies and equity -11.97%1.84B-9.28%1.84B-13.89%1.74B6.90%2.05B15.51%2.08B19.60%2.03B18.81%2.02B13.06%1.91B7.17%1.8B4.81%1.69B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Reservations with explanatory notes------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+1.79%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+1.64%
High Throughput
High Throughput
Intraday+1.40%